|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 284 TWD | -1.56% |
|
-1.90% | +4.41% |
Lotus Pharmaceutical Co., Ltd. (TWSE:1795) entered into an agreement to acquire alimta business of Eli Lilly and Company for $62 million on December 13, 2022. Lotus Pharmaceutical's Board of Directors has approved the acquisition. The completion of this transaction is subject to customary closing conditions.
As of December 31, 2022, Alimta business has reported revenue of $48 million.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 878.4 USD | -0.55% | +3.35% | 791B | ||
| 284 TWD | -1.56% | -1.90% | 2.32B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +4.41% | 2.32B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B | |
| -4.38% | 156B |
LOTUS PHARMACEUTICAL CO., LTD. 